Publication: 181

Identification of Potential Prognostic Biomarkers in Patients with Untreated, Advanced Pancreatic Cancer from a Phase III Trial (CALGB 80303)
      QxMD      Google Scholar   
Citation:
Cancer vol 118 (2) 571-578
Year:
2012
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
1
Parents:
None
Children:
None
Program:
TRP
Primary Committee:
Correl Sci NOS
Sec. Committees:
   
Pharmas:
 
Grants:
CA33601, CA47577, CA32291, CA41287, CA7765, CA77440, CA17145, CA47559, CA45418, U10 CA031946-31, U10 CA031946-29, CA21115, CA31946  
Corr. Author:
 
Authors:
                     
Networks:
 
Study
CALGB-80303
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords:
pancreatic neoplasms, prognosis, biological markers, bevacizumab, alpha 1-antichymotrypsin